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INTRODUCTION
The Memokath® ureteric stent is a thermo-expandable titanium-nickel alloy.(1) Its use is not recommended in stone formers and patients with functional stenosis.(2) Unlike conventional plastic ureteric stents, it is a semi-permanent prosthesis. However, should 
removal be required simply flushing the stent with cold water returns it to a soft and pliable 
form. As these stents do not promote tissue ingrowth, removal is atraumatic. The stent should 
not extend beyond the ureteric orifice into the bladder as this may result in bladder irritability, 
reflux and associated flank pain.(3) 
Herein we report the unusual case of a 49-year old man who presented with urinary inconti-
nence following insertion of a Memokath® ureteric stent three weeks prior. 
CASE REPORT
The stent was inserted to relieve ureteric compression secondary to retroperitoneal fibrosis 
in a solitary kidney. The retroperitoneal fibrosis was thought to be secondary to ankylosing 
spondylitis. Our patient had previously undergone a left nephrectomy as an infant for a non-
functioning kidney, and a proctocolectomy with formation of ileostomy secondary to ulcerative 
colitis. His obstructed solitary kidney was initially identified due loin pain and a raised serum 
creatinine. Abdominal computed tomography confirmed hydronephrosis and a right nephrosto-
my was inserted emergently. Once the serum creatinine had stabilized antegrade and retrograde 
pyelograms demonstrated a 60 mm distal right ureteric stenosis. A retrograde ureteric stent was 
placed with considerable difficulty.
Due to the patients multiple abdominal surgeries and long segment of ureteric occlusion it 
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was felt that ureterolysis or ureteric reimplantation would 
be technically challenging. Consequently, a 100 mm single-
expansion Memokath® 051 ureteric stent was placed as a 
long term solution. At the time of insertion the stenotic seg-
ment of ureter was dilated without significant difficulty (Fig-
ure 1).  Subsequent intra-operative fluoroscopy and cystos-
copy demonstrated that the Memokath® 051 ureteric stent 
was successfully deployed across the compressed ureteric 
segment and not protruding into bladder (Figure 2). Reso-
lution of hydronephrosis was confirmed on post-operative 
renal ultrasound and normal serum creatinine. Three weeks 
later the patient felt a “pop” while urinating and developed 
dysuria and urinary incontinence. There was no macroscopic 
hematuria. The patient presented to the emergency depart-
ment at our hospital and abdominal X-ray demonstrated the 
Memokath® ureteric stent had migrated through the prostatic 
fossa into the anterior urethra (Figure 3). Cystoscopy and re-
moval of the Memokath® ureteric stent was performed with 
resolution of urinary incontinence. A retrograde pyelogram 
was performed which demonstrated resolution of the ureteric 
occlusion. Consequently a ureteric stent was not reinserted. 
He remained well and asymptomatic at his 2, 4, 8 and 16-
week follow-up. Serum creatinine remained normal and se-
rial renal ultrasounds did not demonstrate any evidence of 
hydronephrosis. 
DISCUSSION
Spontaneous resolution of ureteric stricture has been associ-
ated with the use of Memokath® 051 ureteric stents.(4) Mi-
gration of Memokath® ureteral stents occurs in 11%-30% 
of patients. The rate of migration is similar in benign and 
malignant strictures, 22% and 20% respectively.(3) Migration 
may occur due to insufficient anchorage and propulsion by 
antegrade peristalsis.(5) Encrustation and obstruction may oc-
cur in up to 27% of cases.(3) Urinary incontinence secondary 
to stent migration is a rare event, however it can be easily 
diagnosed with a simple abdominal X-ray. 
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Figure 1. Dilatation of stenotic segment of ureter.  
Figure 2.  Intra-operative fluoroscopy demonstrates that the 
Memokath® was successfully deployed across the compressed 
ureteric segment. 
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Figure 3. Abdominal X-ray demonstrates that the Memokath® 
had migrated through the prostatic fossa into the anterior 
urethra. 
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